A/Prof Shaun Fleming is the head of the Myeloid Diseases Service at Alfred Health and a conjoint associate professor at the Australian Centre for Blood Diseases at Monash University. He has a particular interest in acute leukaemia and cellular therapies and leads the leukaemia trial program at The Alfred. His research interests include clinical trials, measurable residual disease monitoring and application of machine learning and artificial intelligence to the prognostication and classification of blood disorders.